Sheel Biotech Limited IPO

Apply 0
Avoid 0

Sheel Biotech Limited (“SBL”) was incorporated as Sheel Biotech Private Limited on November 26, 1991, is engaged in growing, developing, processing, and supplying plants for field crops, fruits, vegetables, and ornamental plants using tissue culture and organic farming techniques. The company also manufactures and maintains greenhouses, provides farmer training through Farmer Producer Organizations (FPOs), and delivers green landscaping services to government and private clients.

Business Segments

1. Tissue Culture Segment: Uses totipotency-based technology to produce plants in a sterile, controlled environment. The Manesar lab, equipped with Dutch technology, has a capacity of 10 million plants per year, supplying both public and government clients.

2. Organic Segment: Focused on organic farming practices and certification for agricultural produce.

3. Planting & Landscaping Segment: Provides green landscaping solutions for private and government projects.

4. Skill & FPO Segment: Operates 50 Farmer Producer Organizations to train farmers and enhance agricultural productivity.

5. Green & Packhouse Segment: Supports post-harvest processing, packaging, and logistics for horticultural products.

Geographical Presence

Headquartered in Delhi, SBL has operations across multiple Indian states, including Assam, Andhra Pradesh, Delhi, Haryana, Telangana, Odisha, Uttar Pradesh and Bihar

Competitive Strengths

i) Over 30 Years of Expertise in plant tissue culture and organic farming.
ii) Strong collaborations with plant breeders in the USA, Europe, and Asia.
iii) Expertise in import procedures, plant quarantine, and global tissue culture operations.
iv) Advanced training for technical experts in India and abroad.
v) Proven track record in managing potato seed tissue culture in Eritrea.
vi) Extensive FPO network supporting agricultural development and organic certification.

Objects of the Sheel Biotech Limited IPO:

Company proposes to utilize the funds towards funding the following objects 1. Capital Expenditure requirements  (₹9.11 cr) 2. Working capital requirement  (₹15.88 cr) 3. General Corporate Purpose

Sheel Biotech Limited IPO Details:

Open Date: Sep 30 2025
Close Date: Oct 03 2025
Total Shares: 54,00,000
Face Value: ₹ 10 Per Equity Share
Issue Type: Book Building
Issue Size: 34.02 Cr.
Lot Size: 2000 Shares
Issue Price: ₹ 59-63 Per Equity Share
Listing At: NSE Emerge
Listing Date: Oct 08 2025

Promoters And Management:

1. Dr. Satya Narayan Chandak (Chairman & Director, Age 75): Appointed Chairman in August 2024, he holds a Doctorate, M.Com, LLB, and B.Com. With 34 years of experience in agriculture, biotechnology, tissue culture, floriculture, dairy, and banking, he oversees finance, budgeting, and government program execution. Recipient of multiple awards, including Rajiv Gandhi National Unity Award and Best Organic Company Award. 2. Dr. Sanjay Chandak (Promoter & Executive Director, Age 54): Holds a Doctorate in Business Administration from California Public University with 27 years of experience in biotechnology, tissue culture, floriculture, seeds, and organic certification. Focuses on technology sourcing and strategic tie-ups for business expansion. 3. Mr. Divye Chandak (Promoter & Managing Director, Age 28): Holds a B.Tech in Chemical Engineering and PG Management, with 7 years of experience in marketing and business development. Manages marketing operations, strategic planning, partnerships, and revenue growth initiatives.

Financials of Sheel Biotech Limited IPO:

Particulars (Cr) FY2024-2025 FY 2023-2024 FY 2022-2023
Revenue from Operations 101.75 92.28 80.11
EBITDA 14.97 14.45 8.82
EBITDA Margins 14.71% 15.56% 11.02%
PAT 10.63 10.47 5.07
PAT Margins 10.45% 11.32% 6.33%
ROCE 16.34% 16.48% 10.75%
Debt to Equity Ratio(In Times) 0.21 0.32 0.3
Operating Cash Flows 9.2 -0.91 9.29

Comparison With Peers:

Companies Revenue (in cr) EBITDA Margins PAT Margins ROCE D/E Ratio MCap (in cr) P/E
Sheel Biotech Limited 101.75 14.71% 10.45% 16.34% 0.21 128.22 12.06
Jain Irrigation System Limited 5732 13% 0.45% 0.61% 0.71 3,765.0 111
Vrundavan Plantation Limited 25.52 10.04% 6.90% 10.40% 0.12 27.8 15.8

Lead Manager of Sheel Biotech Limited IPO:

  1. Narnolia Financial Services Ltd

Registrar of Sheel Biotech Limited IPO:

  1. Skyline Financial Services Private Ltd

Discussion on Sheel Biotech Limited IPO:

Leave a Reply